ANT-DBS in epilepsy shows no effect on selected neuropsychiatric tests.

Helle HerrmanKåre OsnesArild EggeAne KonglundJon Ramm-PettersenEspen Dietrichs Erik Taubøll

Published in: Acta neurologica Scandinavica (2022)

Our results indicate that ANT-DBS has limited effect concerning psychiatric issues. Subjective side effects were, however, reported in individual patients.

Keyphrases

end stage renal disease
deep brain stimulation
chronic kidney disease
newly diagnosed
mental health
peritoneal dialysis
prognostic factors
physical activity
sleep quality
depressive symptoms